Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1327-1332

Spandidos Publications

Access to resources Recommend Favorite

Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

By López Rubio Montserrat   Da Silva Carolina   Loscertales Javier   Seri Cristina   Baltasar Patricia   Colado Enrique   Pérez Fernández Inmaculada   Osma Mar   Gomis Federico   González Marcos   Jarque Isidro   Vargas Manuel   Monzó Encarnación   Monteagudo Dolores   Orts Maria Isabel   Pardal Emilia   Carbonell Félix   Perez Calvo Cesar   Garcia-Marco Jose A.  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1007-1012

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Rituximab in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

By Plosker G.L.   Figgitt D.P.  

American Journal of Cancer, Vol. 2, Iss. 4, 2003-01 ,pp. : 283-289

Adis International

Access to resources Recommend Favorite

Monoclonal antibodies in the treatment of chronic lymphocytic leukemia

By Liu Nina   O’Brien Susan  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 297-304

Humana Press, Inc

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: Prognosis and Treatment Options

By Wierda William G.   Keating Michael J.   O'Brien Susan  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 163-178

Adis International

Access to resources Recommend Favorite